ASCO 2025: Clinical Impact of Practice-Changing Updates in Advanced NSCLC Isabel Preeshagul, DO, MBS | June 18, 2025

https://www.medscape.com/viewarticle/mdangle-asco-2025-advanced-nsclc-clinical-impact-2025a10000et

Is It Worth Adding Chemo to ICI for NSCLC in Older Adults? M. Alexander Otto, PA, MMSc | June 19, 2025

https://www.medscape.com/viewarticle/it-worth-adding-chemo-ici-nsclc-older-adults-2025a1000geb

Empagliflozin Not Linked to Urinary Tract Cancer in T2D Edited by Devyani Gholap Medscape UK June 19, 2025

https://www.medscape.com/viewarticle/empagliflozin-not-linked-urinary-tract-cancer-t2d-2025a1000g4b

Can Modulation of the Microbiome Improve Cancer Immunotherapy Tolerance and Efficacy? Christine Kilgore June 19, 2025

https://www.medscape.com/viewarticle/can-modulation-microbiome-improve-cancer-immunotherapy-2025a1000gev

Genetics or Microenvironment: What Drives CLL Progression? Cristina Ferrario June 19, 2025

https://www.medscape.com/viewarticle/genetics-or-microenvironment-what-drives-cll-progression-2025a1000gf8

Migraine relief before a headache starts The drug, ubrogepant, mitigated many of the symptoms that precede the worst of a migraine and hinted at the condition’s origin.

https://www.drugdiscoverynews.com/migraine-relief-before-a-headache-starts-16453

A new type of injection could improve eye disease treatment To get drugs to reach the choroid and retina, ophthalmologists have relied on imperfect methods with drawbacks. Suprachoroidal delivery could be the fix

https://www.drugdiscoverynews.com/a-new-type-of-injection-could-improve-eye-disease-treatment-16458?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-_PX74nU1K0Hy8RsuED8lQHYd-6w1MJ_l_b8xtJO6rw-pC6ZxxtxU2k8BsHnk74rULw4X9s2R-ATkd41nt_qkYvW5pJ1w&_hsmi=367579052&utm_content=367579052&utm_source=hs_email